biostudies-literatureWang BNCI NIH HHS564-70https://www.ebi.ac.uk/biostudies/studies/S-EPMC4289616biostudies-literatureUnknown119(3)<h4>Objective</h4>To assess the role of active immunotherapy targeting VEGF with a peptide vaccine as a potential treatment for ovarian cancer.<h4>Methods</h4>A peptide vaccine targeting antigenic B-cell epitopes of VEGF were identified and linked to a promiscuous T-cell epitope. Elicited antibodies were assessed for their ability to recognize the VEGF protein, inhibit angiogenesis, inhibit the interaction of VEGF with its receptor, and inhibit cancer growth in mice.<h4>Results</h4>Following immunization, high-titered elicited antibodies were shown to be specific for the full-length VEGF protein by ELISA and Western blot. Anti-VEGF peptide antibodies inhibited cellular migration, proliferation, invasion, tube formation, and growth of aortic ring cultures. These antibodies inhibited the intGynecologic oncologyImmunization with synthetic VEGF peptides in ovarian cancer.PMC4289616P30 CA016058Wang BKaumaya PTCohn DEfalseImmunization with synthetic VEGF peptides in ovarian cancer.<h4>Objective</h4>To assess the role of active immunotherapy targeting VEGF with a peptide vaccine as a potential treatment for ovarian cancer.<h4>Methods</h4>A peptide vaccine targeting antigenic B-cell epitopes of VEGF were identified and linked to a promiscuous T-cell epitope. Elicited antibodies were assessed for their ability to recognize the VEGF protein, inhibit angiogenesis, inhibit the interaction of VEGF with its receptor, and inhibit cancer growth in mice.<h4>Results</h4>Following immunization, high-titered elicited antibodies were shown to be specific for the full-length VEGF protein by ELISA and Western blot. Anti-VEGF peptide antibodies inhibited cellular migration, proliferation, invasion, tube formation, and growth of aortic ring cultures. These antibodies inhibited the int2010-01-01T00:00:00Z2010 Dec2025-06-27T03:05:41.082Z2025-06-27T03:05:41.082ZS-EPMC42896162082280210.1016/j.ygyno.2010.07.037